A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascending

NCT04502901 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

NCT02280603 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy and Safety of AD-208

NCT04825561 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia

NCT06409650 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia

NCT05218642 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Pharmacokinetics and Safety of AD-208

NCT04214808 ·Status: COMPLETED ·Phase: PHASE1

Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia

NCT05296863 ·Status: COMPLETED ·Phase: PHASE3

Phase III Study of KX-826 With Adult Male Patients With AGA

NCT06126965 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.

NCT07011485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

NCT07038941 ·Status: COMPLETED ·Phase: PHASE1

Phase II Study Evaluating the Efficacy and Safety of KX-826

NCT05940506 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata

NCT06104839 ·Status: RECRUITING ·Phase: PHASE2

Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia

NCT05864885 ·Status: UNKNOWN ·Phase: PHASE1

A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)

NCT05244980 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)

NCT04913519 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of VDPHL01 in Males and Females With AGA

NCT06527365 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Minoxidil Response Testing in Males With Androgenetic Alopecia

NCT02198261 ·Status: COMPLETED

Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

NCT05802173 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

NCT06826196 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Hair Regeneration in Androgenetic Alopecia

NCT06066827 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects

NCT05380427 ·Status: COMPLETED ·Phase: PHASE1

A Study of KL130008 in Adults With Severe Alopecia Areata

NCT05496426 ·Status: TERMINATED ·Phase: PHASE2

An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)

NCT06556056 ·Status: COMPLETED ·Phase: NA

Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia

NCT07012486 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss

NCT06355856 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4